Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company is engaged in the field of ophthalmology (eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The Company provides various treatments, suchas ReLEx SMILE, Touchfree Laser, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The Company operates in various locations, such as Sitra, Coimbatore; RS Puram, Coimbatore; Salem; Tirupur; Mettupalayam; Kochi; Mulanthuruthy; Saravanampatty, and Karur.As of 25 May 2026, LOTUS EYE HOSPITAL share price is ₹109.95. The stock opened at ₹111.80, compared to its previous close of ₹109.19. During today's trading session, LOTUS EYE HOSPITAL share price moved in the range of ₹108.20 to ₹112.00, with an average price of ₹110.10 for the day. Looking at its last 52-week, the stock has touched a low of ₹108.20 and a high of ₹112.00. On the performance front, LOTUS EYE HOSPITAL share price has increased by 1.45% over the last six months and is up 50.77% on a year-on-year basis.
The market capitalization of LOTUS EYE HOSPITAL is ₹223 Crs, with a P/E ratio of 345.3 and a dividend yield of 0.00%.